PROCEEDINGS VOLUME 10476
SPIE BIOS | 27 JANUARY - 1 FEBRUARY 2018
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVII
IN THIS VOLUME

6 Sessions, 19 Papers, 0 Presentations
Proceedings Volume 10476 is from: Logo
SPIE BIOS
27 January - 1 February 2018
San Francisco, California, United States
Photodynamic Therapy I
Proc. SPIE 10476, Photodynamic therapy: the role of paraptosis, 1047602 (12 February 2018); doi: 10.1117/12.2291997
Photodynamic Therapy II
Proc. SPIE 10476, Efficient in vitro photodynamic inactivation of Candida albicans by repetitive light doses, 1047608 (12 February 2018); doi: 10.1117/12.2289300
Photodynamic Therapy III
Proc. SPIE 10476, Nanoparticle-based photodynamic therapy on non-melanoma skin cancer, 1047609 (12 February 2018); doi: 10.1117/12.2290145
Proc. SPIE 10476, Light-triggered liposomal cargo delivery platform incorporating photosensitizers and gold nanoparticles for enhanced singlet oxygen generation and increased cytotoxicity, 104760A (12 February 2018); doi: 10.1117/12.2286552
Proc. SPIE 10476, The NPe6 fluorescence measurements by using a fluorescence sensing system for skin photosensitivity risk assessment after photodynamic therapy, 104760D (12 February 2018); doi: 10.1117/12.2287677
Photodynamic Therapy VII
Proc. SPIE 10476, Non-toxic approach for treatment of breast cancer and its cutaneous metastasis: Capecitabine (Xeloda) enhanced photodynamic therapy in a murine tumor model, 104760P (12 February 2018); doi: 10.1117/12.2295820
Proc. SPIE 10476, Low-dose PDT on breast cancer spheroids, 104760S (12 February 2018); doi: 10.1117/12.2290915
Proc. SPIE 10476, High energy photons excited photodynamic cancer therapy in vitro , 104760T (12 February 2018); doi: 10.1117/12.2291252
Photodynamic Therapy VIII
Proc. SPIE 10476, Reactive oxygen species explicit dosimetry (ROSED) of a type 1 photosensitizer, 104760V (12 February 2018); doi: 10.1117/12.2291385
Proc. SPIE 10476, In vitro evaluation of photodynamic therapy using redox-responsive nanoparticles carrying PpIX, 104760W (12 February 2018); doi: 10.1117/12.2288831
Poster Session
Proc. SPIE 10476, Photodynamic inactivation of Staphylococcus aureus and Escherichia coli using a new bacteriochlorin as photosensitizer, 104760X (12 February 2018); doi: 10.1117/12.2286980
Proc. SPIE 10476, HSA/PSS coated gold nanorods as thermo-triggered drug delivery vehicles for combined cancer photothermal therapy and chemotherapy, 104760Z (12 February 2018); doi: 10.1117/12.2289273
Proc. SPIE 10476, Mechanism to preserve phrenic nerve function during photosensitization reaction: drug uptake and photosensitization reaction effect on electric propagation, 1047610 (12 February 2018); doi: 10.1117/12.2289200
Proc. SPIE 10476, 3-compartment talaporfin sodium pharmacokinetic model by optimization using fluorescence measurement data from canine skin to estimate the concentration in interstitial space, 1047611 (12 February 2018); doi: 10.1117/12.2289199
Proc. SPIE 10476, Photodynamic inactivation using curcuminoids and Photogem on caenorhabditis elegans, 1047612 (12 February 2018); doi: 10.1117/12.2283242
Proc. SPIE 10476, Influence of different coupling agents on the light-phantom interface, 1047613 (12 February 2018); doi: 10.1117/12.2288524
Proc. SPIE 10476, Improvement of the light-tissue coupling for better outcome of phototherapies, 1047614 (12 February 2018); doi: 10.1117/12.2288515
Proc. SPIE 10476, Subcellular localization and photodynamic activity of Photodithazine (glucosamine salt of chlorin e6) in murine melanoma B16-F10: an in vitro and in vivo study, 1047616 (12 February 2018); doi: 10.1117/12.2283241
Proc. SPIE 10476, Verteporfin heterogeneity in pancreatic adenocarcinoma and the relationship to tumor vasculature and collagen distribution , 1047617 (12 February 2018); doi: 10.1117/12.2309291
Back to Top